STRAP Strategic Partners A/S

81.44USD555.00 DKK · CPH-2.63%Mkt Cap: 4.41M USDP/E: 17.90

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 202…

Key Statistics

Company
Market Cap4.41M USD
Enterprise Value971.74K USD
Revenue (TTM)44.61K USD
Gross Profit44.61K USD
Net Income (TTM)-126.05K USD
Revenue/Share1.07 USD
Last Price81.44 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryDK
SectorHealthcare
IndustryBiotechnology
ISINDK0062502894
Valuation
P/E (Trailing)17.90
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue21.78
P/S98.79
P/B1.19
EPS (TTM)4.55 USD
EPS (Forward)—
52W Range
75.579% of range138.82
52W High138.82 USD
52W Low75.57 USD
Profitability
Gross Margin100.00%
Oper. Margin-651.97%
EBITDA Margin0.00%
Profit Margin-277.99%
ROE-4.67%
ROA-4.40%
ROIC—
ROCE-13.30%
Growth
Revenue Growth-4.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-313.44K USD
CapEx (TTM)—
FCF Margin-410.44%
FCF Yield-4.15%
Net Debt-2.43M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio23.55
Quick Ratio23.55
Book Value/Sh68.27 USD
Cash/Share58.14 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateDec 6, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.11K
Float4.41K
Insiders68.93%
Institutions4.84%
Technical
SMA 5092.42 (-11.9%)
SMA 20092.02 (-11.5%)
Beta0.20
S&P 52W Chg12.00%
Avg Vol (30d)35
Avg Vol (10d)11
Technical Indicators
RSI (14)34.6
MACD-22.5932
MACD Signal-19.8099
MACD Hist.-2.7834
BB Upper96.67 USD
BB Middle87.90 USD
BB Lower79.12 USD
BB Width19.96%
ATR (14)3.478 USD
Vol Ratio (20d)1.06x

About Strategic Partners (CPH: STRAP)

›

Strategic Partners (CPH: STRAP) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 1 employees.

The shares were at 555.00 DKK on 19 November 2026, down 32.8% over 52 weeks. Its 52-week range is 515.00 DKK to 946.00 DKK: the price is 41.3% below the high and 7.8% above the low.

At a market capitalisation of 30.03M DKK, it trades at 17.9 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a discount of 47% for STRAP.

Strategic Partners reports return on equity of -4.7% and revenue down 4.8% year over year.

It holds more cash than debt, a net cash position of 16.53M DKK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.